Federal Agency for Medicines and Health Products (FAMHP)

famhp.be Imported from official source

Regulator in Belgium; safety publications from its own official source.

Publications 33

  1. Keytruda

    Keytruda Active substance Pembrolizumab Holder MSD Belgium BV/SRL Status Running Indication in combination with paclitaxel with or without bevacizumab, is indicated for the treatment of platinum-re...

    Announcement Safety
  2. Webinaire sur le rôle et les activités de l’unité National Innovation Office et Avis scientifique-technique - Inscrivez-vous dès maintenant

    The Federal Agency for Medicines and Health Products invites you to a webinar on the Scientific-Technical Advice Unit and the National Innovation Office. Tuesday 15 December 2026, from 9.00 am to 1...

    Announcement Safety
  3. Enhertu

    Enhertu Active substance Trastuzumab deruxtecan Holder     Daiichi Sankyo Belgium N.V.-S.A Status Running Indication treatment of adult patients with unresectable or metastatic HER2-...

    Announcement Safety
  4. Dates limites pour la soumission de dossiers en période de fin d'année

    During the end-of-year period, the FAMHP will be closed from Friday 25 December 2026 to Friday 1 January 2027. Deadlines have been set for the submission of different types of dossiers. Dossiers fo...

    Announcement Safety 2 versions
  5. Nieuwe MDCG-richtsnoer ondersteunt ontwikkeling van diagnostische testen voor zeldzame aandoeningen

    The Medical Device Coordination Group (MDCG) has published new guidance on clinical evidence for so-called ‘orphan IVDs’. These diagnostic tests are intended for use in rare conditions or in except...

    Announcement Safety
  6. FAGG sluit zich aan bij wereldwijde MedSafetyWeek-campagne met de oproep: ‘Negeer bijwerkingen niet, meld ze’.

    The global MedSafetyWeek campaign takes place this week. The message is clear: ‘Don’t ignore suspected side effects, report them’. By doing so, you can help protect others. With 140 organisations a...

    Announcement Safety
  7. Akeega

    Akeega Active substance Niraparib and abiraterone acetate Holder Janssen-Cilag NV Status Running Indication with prednisone or prednisolone and in combination with androgen deprivation therapy (ADT...

    Announcement Safety
  8. Les analogues du GLP-1 et les doubles analogues GIP/GLP-1 : risques associés au mésusage et à l’utilisation hors indication pour la perte de poids

    The FAMHP has been alerted to cases of misuse and off-label use of GLP-1 analogues and GIP/GLP-1 dual analogues, particularly for the purpose of weight loss. Here are a few reminders about the prop...

    Announcement Safety
  9. Garantir l’accès aux traitements aujourd’hui et préparer ceux de demain

    Fewer medicine shortages, stronger dialogue with patients and support for innovation: in 2025, the Federal Agency for Medicines and Health Products once again demonstrated the diversity of its resp...

    Announcement Safety
  10. Journée Vigilance 2026 : inscrivez-vous dès maintenant

    This year’s theme is ‘50 years of pharmacovigilance in Belgium’. …

    Announcement Safety
  11. Vitamine D3 (colécalciférol) : attention aux différents dosages

    The availability of numerous vitamin D3-containing products, which differ considerably in strength, pharmaceutical form, indications and dosage regimens, including within the same product range, co...

    Announcement Safety Source page stopped responding
  12. Matières premières: Soumettre une demande d’autorisation générale d'activité

    Raw materials: Submission of an application for a general activity authorisation There is no predefined form for applying for a general authorisation for the manufacturing, import or distribution o...

    Announcement Safety
  13. SoHO EU Platform

    SoHO EU Platform The EU SoHO Platform is a European digital tool designed to register activities and facilitate the exchange of information on SoHOs throughout the European Union. robert.roman Tue,...

    Announcement 2 versions
  14. FAQ - SoHO

    FAQ - SoHO / robert.roman Tue, 10/13/2026 - 13:55

    Announcement 2 versions
  15. Inspection et autorisation

    From 7 August 2027, SoHO entities will be required to comply with Regulation (EU) 2024/1938 and complete the procedures applicable to their category. Prepare a Preparation Process Dossier (PPD), wh...

    Announcement 2 versions
  16. SoHO critiques

    A critical Substance of Human Origin (SoHO) is a SoHO whose insufficient availability could result in serious harm, or a risk of serious harm, to the health of recipients, or could compromise the m...

    Announcement 2 versions
  17. Préparations à base de SoHO

    is a final product that has undergone processing (manipulation, treatment or preservation) from a SoHO and, where applicable, one or more additional SoHO activities; is intended for a specific clin...

    Announcement 2 versions
  18. Informations générales

    Regulation (EU) 2024/1938 will become applicable on 7 August 2027. Regulation (EU) 2024/1938 establishes a harmonised framework across the European Union and sets high standards to ensure the quali...

    Announcement 2 versions
  19. Jascayd

    Jascayd Active substance Nerandomilast Holder Boehringer Ingelheim International GmbH Status Running Indication Treatment of adult patients with progressive pulmonary fibrosis Public documents Appr...

    Announcement Safety
  20. Jascayd

    Jascayd Active substance Nerandomilast Titulaire Boehringer Ingelheim International GmbH Holder Running Indication Treatment of adult patients with idiopathic pulmonary fibrosis Public documents Ap...

    Announcement Safety
  21. Campagne nationale de 10 jours sur les psychotropes : un usage adapté, à favoriser ensemble !

    The national campaign ‘Psychotropic substances: 10 days of awareness campaign, together for an appropriate use’ runs until 10 October and focuses on the appropriate use of sleep medication and anti...

    Announcement Safety
  22. État d’avancement du « Plan de reprise pour la supervision des centres de fertilité » : actions réalisées et mesures en cours

    In order to guarantee a high standard of safety and quality in gamete donations in Belgium and to strengthen the supervision of fertility centres in the long term, the Federal Agency for Medicines ...

    Announcement Safety 2 versions
  23. Tepkinly

    Tepkinly Active substance Epcoritamab Holder AbbVie Belgium SA/NV Status Running Indication Epcoritamab in combination with lenalidomide and rituximab (R²) for the treatment of relapsed or refracto...

    Announcement Safety
  24. Campagne de vaccination contre la grippe saisonnière 2026-2027

    The seasonal flu vaccination campaign will begin in Belgium from mid-October 2026. In total, more than 2,900,000 flu vaccines will be available for the 2026 - 2027 flu season. The total number of v...

    Announcement Safety
  25. PRAC september 2026: veiligheidsonderzoek naar injecteerbare ijzerhoudende geneesmiddelen

    During its September 2026 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has started the review of injectable iron-containing medicines. The review will a...

    Announcement Safety
  26. Nouveau guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

    New guidance for sponsors on the synchronised procedure for combined CTR–MDR/IVDR studies Publication date 14/09/2026 emily.clayton Mon, 09/14/2026 - 08:58 A new guidance for sponsors on the synchr...

    Announcement Safety
  27. Guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

    Guidance for sponsors on the synchronised procedure for combined CTR–MDR/IVDR studies Belgium offers a synchronised submission procedure for combined studies involving medicinal products and medica...

    Announcement Safety
  28. Enregistrement des antibiotiques dans VAMREG : e-learning pour les vétérinaires

    Since 1 July 2026, the use of antibiotics in all horses and aquaculture fish (intended for food production) must be recorded in the VAMREG application. The FAMHP and AMCRA are offering an e-learnin...

    Announcement Education
  29. 50 ans de pharmacovigilance en Belgique : Save the Date

    50 years of pharmacovigilance in Belgium: save the date Publication date 02/09/2026 Virone.Letizia Wed, 09/09/2026 - 14:31 The Federal Agency for Medicines and Health Products (FAMHP) is pleased to...

    Announcement Safety
  30. Dépassements de quotas : l’AFMPS poursuit ses travaux et renforce la transparence

    Following the press articles published today concerning a new case of quota exceedance involving a foreign gamete donor, as well as the publication of the relevant information on its website, the F...

    Announcement Safety
  31. À partir du 1e septembre 2026 : nouvelle version du formulaire de demande d'autorisation de mise sur le marché pour les procédures nationales, de reconnaissance mutuelle et décentralisées

    Applicants and marketing authorisation holders can now use the new version (1.28.0.0) of the Marketing Authorisation Application Form for national, mutual recognition and decentralised procedures. ...

    Announcement Safety
  32. Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden

    On 27 July 2026, Implementing Regulation (EU) 2026/1810 was published concerning the update of the list of essential substances for food-producing horses. This Regulation entered into force on the ...

    Announcement Safety
  33. Model van diergeneeskundig voorschrift: nieuwe verplichte vermeldingen

    Since January 2022 veterinarians have the obligation to use a new model for veterinary prescriptions. This new model is being introduced in several stages. Since 1 July 2026, the animal species mus...

    Announcement Safety

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.